Home ⟩ Insights

Insights

fda

5 min read • October 12, 2022

Key Marijuana Executive Changes You Need To Know About: FDA, Humble & More

3 min read • September 28, 2022

FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator

3 min read • September 20, 2022

FDA Says No Way To Food Companies Wanting To Get On The CBD Gravy Train

1 min read • September 16, 2022

India Globalization Capita Just Got FDA Approval To Start Enrolling Their Phase 2 Alzheimer Trial With IGC-AD1, A Cannabis Drug

4 min read • September 7, 2022

E-Cigarette Maker To Pay Over $430M To Settle Multi-State Vaping Inquiry, Cannabis Investors Need To Pay Attention

3 min read • August 24, 2022

Taking Care Of Cannabis Consumers, Federal Trade Commission Issues Refunds To CBD Buyers, Here’s Why

2 min read • August 1, 2022

Senate Marijuana & Psychedelics Reforms: Appropriations Committee Chair Patrick Leahy Marks 12 Bills For FY 2023

3 min read • July 25, 2022

Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana

3 min read • July 14, 2022

As Cannabis Industry Grows, So Do Court Cases And Litigation, Here’s A Look At Emerging Trends

2 min read • July 14, 2022

FDA Impact On CBD Market: With Federal Regulation, CBD Sales Would Hit $11B By 2027, Without It? $4.5B Less

2 min read • July 5, 2022

What Is The Role Of The FDA In Measures Taken By Hawaii Officials Against A CBD Company?

4 min read • June 23, 2022

Congress Urges USDA & FDA To Resolve ‘Hot’ Hemp Difficulties, Addresses CBD Advertising, Veterans & Cannabis Research, Psychedelics

Latest Headlines

3 min read • September 1, 2026

Ascend Wellness Takes Step Toward U.S. Exchange Listing, Gets Green Light For Reverse Stock Split

13 min read • September 1, 2026

Boris Jordan Might Be Talking Aurora’s Dispersed Shareholder Structure Into Free-Riding the Deal

6 min read • September 1, 2026

Germany Just Ended Insurance Coverage for Cannabis Flower. Most Patients Will Keep Buying, but Not at the Price Insurers Were Paying.

4 min read • August 31, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 2

5 min read • August 31, 2026

Glass House, America’s Largest Cannabis Grower by Canopy, Rings the NYSE Bell

6 min read • August 31, 2026

USCR Urges Congress to Keep the Hemp Loophole Closed

4 min read • August 28, 2026

Inside DEA Marijuana Rescheduling Hearing: Key Takeaways, Part 1

3 min read • August 28, 2026

$10 Million in Taxpayer Money Was Diverted Into Florida’s Fight Against Marijuana Legalization, Grand Jury Says

2 min read • August 28, 2026

PharmaCielo Revenue Surges 330%; European Cannabis Flower Sales Take Off

5 min read • August 27, 2026

Massachusetts Could Kill Its $1.6 Billion Cannabis Market and Close 300+ Stores, CEO Warns

2 min read • August 27, 2026

IM Cannabis Implements 30-for-1 Reverse Stock Split as It Fights to Maintain Nasdaq Listing

4 min read • August 26, 2026

Four Things Nobody Told You About the DEA Cannabis Hearings — But You Probably Wanted to Ask

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.